UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000027817 |
|---|---|
| Receipt number | R000031863 |
| Scientific Title | Kumamoto University Malignancy and Atheroscrelosis study |
| Date of disclosure of the study information | 2017/06/19 |
| Last modified on | 2018/02/12 08:05:45 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Kumamoto University Malignancy and Atheroscrelosis study
Acronym
KUMA study
Scientific Title
Kumamoto University Malignancy and Atheroscrelosis study
Scientific Title:Acronym
KUMA study
Region
| Japan |
Condition
Condition
Coronary artery disease
Classification by specialty
| Cardiology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The three major causes of death of the Japanese are malignant diseases, heart diseases, cerebrovascular diseases, and with the progress of aging society, opportunities to treat these disease groups tend to increase. Atherosclerotic diseases derived from lifestyle diseases such as myocardial infarction, angina pectoris, peripheral artery disease, aneurysm, cerebral infarction and the like are often conflicting and not coincidental, and in university hospitals with many complicated diseases in particular This tendency is strong, and there are times when you have difficulty in prioritizing treatment. At the present time, the coexistence rate and association of malignant tumor and atherosclerotic disease is not sufficiently clarified.
Basic objectives2
Others
Basic objectives -Others
Coexistence rate of atherosclerotic disease and malignant disease will be clarified by retrospective multidisciplinary collaborative observation research.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
In the patients with malignant disease, the history of the atherosclerosis disease and the morbidity rate are investigated.
We also investigate malignant disease complications and past history in patients with atherosclerosis disease.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 100 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Those who received percutaneous coronary intervention in our department.
Key exclusion criteria
None
Target sample size
1000
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Daisuke Sueta |
Organization
Kumamoto University
Division name
Cardiovacular Medicine
Zip code
Address
1-1-1 Honjo
TEL
096-373-5175
sueta-d@kumamoto-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Daisuke Sueta |
Organization
Kumamoto University
Division name
Cardiovacular Medicine
Zip code
Address
1-1-1 Honjo
TEL
096-373-5175
Homepage URL
sueta-d@kumamoto-u.ac.jp
Sponsor or person
Institute
Kumamoto University
Institute
Department
Personal name
Funding Source
Organization
Self funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 06 | Month | 19 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Main results already published
Date of protocol fixation
| 2017 | Year | 06 | Month | 19 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 06 | Month | 19 | Day |
Last follow-up date
| 2017 | Year | 06 | Month | 19 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
None
Management information
Registered date
| 2017 | Year | 06 | Month | 19 | Day |
Last modified on
| 2018 | Year | 02 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031863
